Apoptotic and proliferative activity in the neoplastic progression of Barrett's oesophagus: A comparative study

Journal of Pathology

Volumn 187, Issue 5, 1999, Pages 535-540

  Whittles, Cheryl E ^a   Biddlestone, Leigh R ^a   Burton, Andrea ^b   Barr, Hugh ^a   Jankowski, Janusz A Z ^b   Warner, Philip J ^a   Shepherd, Neil A ^a,c  

^a CRANFIELD UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

Adenocarcinoma; Apoptosis; Barrett's oesophagus; Dysplasia; Proliferation

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; APOPTOSIS; ARTICLE; BARRETT ESOPHAGUS; CANCER GROWTH; CANCER RISK; CELL DIVISION; CELL PROLIFERATION; CLINICAL ARTICLE; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT TRANSFORMATION; METAPLASIA; PRECANCER; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; ANALYSIS OF VARIANCE; APOPTOSIS; BARRETT ESOPHAGUS; CELL DIVISION; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS;

EID: 0033036928     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199904)187:5<535::AID-PATH302>3.0.CO;2-G     Document Type: Article

References (26)

1. Hall P, Coates P, Ansari B, Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci 1994; 107: 3569-3577.
2. Martin S, Green D. Apoptosis and cancer: the failure of controls on cell death and cell survival. Crit Rev Oncol Hematol 1995; 18: 137-153.
3. Bedi A, Paricha P, Akhtar A, et al. Inhibition of apoptosis during development of colorectal cancer. Cancer Res 1995; 55: 1811-1816.
4. Mooney E, Peris J, O'Neill A, Sweeney E. Apoptotic and mitotic indices in malignant melanoma and basal cell carcinoma. J Clin Pathol 1995; 48: 242-244.
5. Siersema P, Dees J, Tilanus H, Kok T, Hordijk M, van Blankenstein M. Early detection and treatment of oesophageal and gastric cancer. Neth J Med 1995; 47: 76-86.
6. Menke-Pluymers M, Hop W, Dees J, van Blankenstein M, Tilanus H. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. Cancer 1993; 72: 1155-1158.
7. Falk G, Richter J. Reflux disease and Barrett's esophagus. Endoscopy 1996; 28: 13-21.
8. Spechler S, Goyal R. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 1996; 110: 614-621.
9. Drewitz D, Sampliner R, Garewal H. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed for 4·8 years. Am J Gastroenterol 1997; 92: 212-215.
10. Reid B, Sanchez C, Blount P, Levine D. Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression. Gastroenterology 1993; 105: 119-129.
11. Wright T, Kingsnorth A. Barrett's oesophagus and markers of malignant potential. Eur J Gastroenterol Hepatol 1994; 6: 656-662.
12. Gavrieli Y, Sherman Y, Ben Sasson S. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
13. Oberhammer F, Wilson J, Dive C, et al. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 1993; 12: 3679-3684.
14. Save V, Coates PJ, Hall PA. Analysis of apoptosis in tissue sections. In: Brown R, Boger-Brown U, eds. Cytotoxic Drug Resistance Mechanisms, Methods in Molecular Biology. Humana Press, in press.
15. Teter K, Holloway D, Sandinsky G. Assessment of PCNA (19A2) and Ki67 (MIB-1) cell proliferation markers in formalin fixed tissues. J Histotechnol 1995; 18: 99-104.
16. Potten C. Epithelial cell growth and differentiation: II. Intestinal apoptosis. Am J Physiol 1997; 273: G253-G257.
17. Frisch SM, Francis H. Disruption of epithelial cell matrix interactions induces apoptosis. J Cell Biol 1994; 124: 619-626.
18. Potten C, Wilson J, Booth C. Regulation and significance of apoptosis in the stem cells of the gastrointestinal epithelium. Stem Cells 1997; 15: 82-93.
19. Arai T, Kino I. Role of apoptosis in modulation of the growth of human colorectal tubular and villous adenomas. J Pathol 1995; 176: 37-44.
20. Sinicrope F, Roddey G, McDonnell T, Shen Y, Cleary K, Stephens L. Increased apoptosis accompanies neoplastic development in the human colorectum. Clin Cancer Res 1996; 2: 1999-2006.
21. Saegusa M, Takano Y, Okayasu I. Bcl-2 expression and its association with cell kinetics in human gastric carcinomas and intestinal metaplasia. Jpn J Cancer Res Clin Oncol 1995; 121: 357-363
22. Müller W, Schneiders A, Meier S, Hommel G, Gabbert H. Immunohistochemical study on the prognostic value of MIB-1 in gastric carcinoma. Br J Cancer 1996; 74: 759-765.
23. Hong M, Laskin W, Herman B, et al. Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus. Cancer 1995; 75: 423-429.
24. Lauwers GY, Kandemir O, Kubilis PS, Scott GV. Cellular kinetics in Barrett's epithelium carcinogenic sequence: roles of apoptosis, bcl-2 protein, and cellular proliferation. Mod Pathol 1997; 10: 1201-1208.
25. Halm U, Tannapfel A, Breitung B, Marx C, Breidert M, Mössner J. Apoptosis is decreased during the metaplasia-dysplasia-carcinoma-sequence in Barrett's esophagus. Gastroenterology 1997; 112: A574.
26. Polkowski W, Baak J, van Lanschot J, et al. Clinical decision making in Barrett's oesophagus can be supported by computerized immunoquantitation and morphometry of features associated with proliferation and differentiation. J Pathol 1998; 184: 161-168.